Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis
Release Date: June 2019
|Persons at high risk of HIV acquisition|
The USPSTF recommends that clinicians offer preexposure prophylaxis (PrEP) with effective antiretroviral therapy to persons who are at high risk of HIV acquisition.
Current as of: June 2019
Internet Citation: Final Update Summary: Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis. U.S. Preventive Services Task Force. June 2019.